Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B4f61a9159e7861d4f02039a3d8cbbf5a> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B4f61a9159e7861d4f02039a3d8cbbf5a NCIT_P378 "NCI" @default.
- B4f61a9159e7861d4f02039a3d8cbbf5a type Axiom @default.
- B4f61a9159e7861d4f02039a3d8cbbf5a annotatedProperty IAO_0000115 @default.
- B4f61a9159e7861d4f02039a3d8cbbf5a annotatedSource NCIT_C188903 @default.
- B4f61a9159e7861d4f02039a3d8cbbf5a annotatedTarget "A regimen consisting of polatuzumab vedotin, bendamustine and rituximab that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL)." @default.